GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Episurf Medical AB (OSTO:EPIS B) » Definitions » Change In Receivables

Episurf Medical AB (OSTO:EPIS B) Change In Receivables : kr-1.70 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Episurf Medical AB Change In Receivables?

Episurf Medical AB's change in receivables for the quarter that ended in Mar. 2025 was kr-1.60 Mil. It means Episurf Medical AB's Accounts Receivable increased by kr1.60 Mil from Dec. 2024 to Mar. 2025 .

Episurf Medical AB's change in receivables for the fiscal year that ended in Dec. 2024 was kr-2.60 Mil. It means Episurf Medical AB's Accounts Receivable increased by kr2.60 Mil from Dec. 2023 to Dec. 2024 .

Episurf Medical AB's Accounts Receivable for the quarter that ended in Mar. 2025 was kr2.30 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Episurf Medical AB's Days Sales Outstanding for the three months ended in Mar. 2025 was 52.47.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Episurf Medical AB's liquidation value for the three months ended in Mar. 2025 was kr17.28 Mil.


Episurf Medical AB Change In Receivables Historical Data

The historical data trend for Episurf Medical AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Episurf Medical AB Change In Receivables Chart

Episurf Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.60 -1.60 1.20 0.40 -2.60

Episurf Medical AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 0.90 -0.40 -0.60 -1.60

Episurf Medical AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Episurf Medical AB  (OSTO:EPIS B) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Episurf Medical AB's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2.3/4*91
=52.47

2. In Ben Graham's calculation of liquidation value, Episurf Medical AB's accounts receivable are only considered to be worth 75% of book value:

Episurf Medical AB's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=32.6-18.6+0.75 * 2.3+0.5 * 3.1
=17.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Episurf Medical AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of Episurf Medical AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Episurf Medical AB Business Description

Traded in Other Exchanges
Address
Karlavagen 60, Stockholm, SWE, 114 49
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint.

Episurf Medical AB Headlines

No Headlines